Subchronic exposure represents a middle ground between acute and chronic exposure, usually spanning from one month to three months. It is particularly useful for assessing the intermediate risks of a substance and helps in understanding dose-response relationships over a manageable time frame. This type of study is often used in the developmental stages of pharmaceutical testing.
